
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $37.5K | -- | -- | -$0.25 | -- |
08/13/2025 | Q2 | $10K | -- | -- | -$0.25 | -- |
05/15/2025 | Q1 | $10K | $8K | $0.34 | -$0.29 | $0.63 |
03/25/2025 | Q4 | $20K | $10K | $0.11 | -$0.40 | $0.51 |
11/14/2024 | Q3 | $1.1M | $996K | $1.44 | -$1.30 | $2.74 |
08/13/2024 | Q2 | $1.2M | $979K | -$1.19 | -$1.34 | $0.15 |
05/14/2024 | Q1 | $1M | $1M | -$2.62 | -$1.55 | -$1.07 |
03/27/2024 | Q4 | $1M | $1M | -$1.93 | -$1.79 | -$0.14 |
11/14/2023 | Q3 | $658K | $791K | -$2.38 | -$2.10 | -$0.28 |
08/16/2023 | Q2 | $525K | $166K | -$2.10 | -$2.33 | $0.23 |
05/17/2023 | Q1 | -- | $446K | -$2.78 | -- | -- |
03/14/2023 | Q4 | -- | $112K | -$3.33 | -- | -- |
11/15/2022 | Q3 | -- | $76K | -$4.35 | -- | -- |
08/15/2022 | Q2 | -- | -- | -$4.35 | -- | -- |
05/12/2022 | Q1 | -- | $189K | -$3.00 | -- | -- |
03/29/2022 | Q4 | -- | $300K | -$3.45 | -- | -- |
11/16/2021 | Q3 | -- | $200K | -$2.25 | -- | -- |
08/12/2021 | Q2 | -- | -- | -$2.10 | -- | -- |
05/17/2021 | Q1 | -- | -- | -$1.95 | -- | -- |
02/22/2021 | Q4 | -- | -- | -$2.40 | -- | -- |
11/17/2020 | Q3 | -- | -- | -$1.65 | -- | -- |
08/18/2020 | Q2 | -- | -- | -$1.95 | -- | -- |
04/09/2020 | Q1 | -- | -- | -$4.95 | -- | -- |
12/31/2019 | Q4 | -- | -- | -$2.85 | -- | -- |
11/21/2019 | Q3 | -- | -- | -$1.50 | -- | -- |
09/05/2019 | Q2 | -- | -- | -$1.95 | -- | -- |
04/04/2019 | Q1 | -- | -- | -$1.95 | -- | -- |
12/31/2018 | Q4 | -- | -- | -$4.05 | -- | -- |
11/15/2018 | Q3 | -- | -- | -$1.80 | -- | -- |
08/14/2018 | Q2 | -- | -- | -$4.05 | -- | -- |
04/11/2018 | Q1 | -- | -- | -$3.15 | -- | -- |
12/31/2017 | Q4 | -- | -- | $0.45 | -- | -- |
11/15/2017 | Q3 | -- | -- | -$6.00 | -- | -- |
08/14/2017 | Q2 | -- | -- | -$1.20 | -- | -- |
03/31/2017 | Q1 | -- | -- | -$4.80 | -- | -- |
02/22/2017 | Q4 | -- | -- | -$1.95 | -- | -- |
12/07/2016 | Q3 | -- | -- | -$2.10 | -- | -- |
08/17/2016 | Q2 | -- | -- | -$1.50 | -- | -- |
03/31/2016 | Q1 | -- | -- | -$0.79 | -- | -- |
12/31/2015 | Q4 | -- | -- | -$0.81 | -- | -- |
09/30/2015 | Q3 | -- | -- | -$0.60 | -- | -- |
PAVmed reported $8K worth of top line sales in its most recent quarter.
PAVmed announced earnings per share of $0.34 which represents a beat of analyst forecast a -$0.29 per share.
PAVmed reported -$28K that represents -$0.00 per share over the last quarter.
PAVmed's earnings are forecast to decrease from $0.50 per share to -$2.69 per share next year representing a decrease of -70.63%.
PAVmed's next earnings date is August 13, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.